These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 33972996)

  • 1. A Multicenter Evaluation of Probiotic Use for the Primary Prevention of Clostridioides difficile Infection.
    Heil EL; Harris AD; Brown C; Seung H; Thom KA; von Rosenvinge E; Sorongon S; Pineles L; Goodman KE; Leekha S
    Clin Infect Dis; 2021 Oct; 73(8):1330-1337. PubMed ID: 33972996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
    Wombwell E; Patterson ME; Bransteitter B; Gillen LR
    Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Bio-K+ for the prevention of
    Leal J; Shen Y; Faris P; Dalton B; Sabuda D; Ocampo W; Bresee L; Chow B; Fletcher JR; Henderson E; Kaufman J; Kim J; Raman M; Kraft S; Lamont NC; Larios O; Missaghi B; Holroyd-Leduc J; Louie T; Conly J
    Infect Control Hosp Epidemiol; 2024 Apr; 45(4):443-451. PubMed ID: 38073551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Probiotic for Primary Prevention of Clostridium difficile Infection: A Single-Center Before-and-After Quality Improvement Intervention at a Tertiary-Care Medical Center.
    Trick WE; Sokalski SJ; Johnson S; Bunnell KL; Levato J; Ray MJ; Weinstein RA
    Infect Control Hosp Epidemiol; 2018 Jul; 39(7):765-770. PubMed ID: 29695310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation strategies for hospital-based probiotic administration in a stepped-wedge cluster randomized trial design for preventing hospital-acquired Clostridioides difficile infection.
    Bresee LC; Lamont N; Ocampo W; Holroyd-Leduc J; Sabuda D; Leal J; Dalton B; Kaufman J; Missaghi B; Kim J; Larios OE; Henderson E; Raman M; Fletcher JR; Faris P; Kraft S; Shen Y; Louie T; Conly JM
    BMC Health Serv Res; 2023 Dec; 23(1):1386. PubMed ID: 38082421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescribed probiotic usage to prevent Clostridioides difficile infection among older patients receiving antibiotics: A retrospective cohort study.
    Mori N; Katsumata T; Takahashi T
    J Infect Chemother; 2023 Sep; 29(9):833-837. PubMed ID: 37211085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics for primary prevention of
    Fajnzylber J; Patterson W; Deshpande A
    Curr Med Res Opin; 2023 Jun; 39(6):889-891. PubMed ID: 37078551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perils and pitfalls of probiotic quasi-experimental studies for primary prevention of Clostridioides difficile infection: A review of the evidence.
    McFarland LV; Johnson SB; Evans CT
    Am J Infect Control; 2021 Mar; 49(3):375-384. PubMed ID: 32791261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of probiotics on the incidence of Clostridioides difficile: Retrospective cohort analysis.
    Saltzman T; Fazzari M; Chung S; Cunha BA; Blum S
    Am J Infect Control; 2020 Feb; 48(2):184-188. PubMed ID: 31606256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-Discharge
    Jachowicz E; Pac A; Różańska A; Gryglewska B; Wojkowska-Mach J
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328843
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of Clostridioides difficile infection (CDI) related to antibiotic prescribing by GP surgeries in Wales.
    Tydeman F; Craine N; Kavanagh K; Adams H; Reynolds R; McClure V; Hughes H; Hickman M; Robertson C
    J Antimicrob Chemother; 2021 Aug; 76(9):2437-2445. PubMed ID: 34151964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of Global Strategies to Prevent Hospital-Onset Clostridium difficile Infection: Targeting Proton Pump Inhibitors and Probiotics.
    Lewis PO; Lundberg TS; Tharp JL; Runnels CW
    Ann Pharmacother; 2017 Oct; 51(10):848-854. PubMed ID: 28821215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Institutional review of the implementation and use of a Clostridium difficile infection bundle and probiotics in adult trauma patients.
    Bommiasamy AK; Connelly C; Moren A; Dodgion C; Bestall K; Cline A; Martindale RG; Schreiber MA; Kiraly LN
    Am J Surg; 2018 May; 215(5):825-830. PubMed ID: 29490870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridioides difficile Infection in Children: The Role of Infection Prevention and Antimicrobial Stewardship.
    Savage TJ; Sandora TJ
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S64-S68. PubMed ID: 34791402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis.
    Pattani R; Palda VA; Hwang SW; Shah PS
    Open Med; 2013; 7(2):e56-67. PubMed ID: 24348885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial Preparations (Probiotics) for the Prevention of Clostridium difficile Infection in Adults and Children: An Individual Patient Data Meta-analysis of 6,851 Participants.
    Johnston BC; Lytvyn L; Lo CK; Allen SJ; Wang D; Szajewska H; Miller M; Ehrhardt S; Sampalis J; Duman DG; Pozzoni P; Colli A; Lönnermark E; Selinger CP; Wong S; Plummer S; Hickson M; Pancheva R; Hirsch S; Klarin B; Goldenberg JZ; Wang L; Mbuagbaw L; Foster G; Maw A; Sadeghirad B; Thabane L; Mertz D
    Infect Control Hosp Epidemiol; 2018 Jul; 39(7):771-781. PubMed ID: 29695312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of the Targeted Assessment for Prevention Strategy in a healthcare system to reduce
    White KA; Soe MM; Osborn A; Walling C; Fike LV; Gould CV; Kuhar DT; Edwards JR; Cochran RL
    Infect Control Hosp Epidemiol; 2020 Mar; 41(3):295-301. PubMed ID: 31928537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chasing the rate: An interrupted time series analysis of interventions targeting reported hospital onset
    Doll ME; Zhao J; Kang L; Rittmann B; Alvarez M; Fleming M; Cooper K; Stevens MP; Bearman G
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1142-1147. PubMed ID: 32493530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Clostridium difficile infection and predictive impact of probiotic use in a diverse hospital-wide cohort.
    Carvour ML; Wilder SL; Ryan KL; Walraven C; Qeadan F; Brett M; Page K
    Am J Infect Control; 2019 Jan; 47(1):2-8. PubMed ID: 30205907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Decade of Experience in Primary Prevention of Clostridium difficile Infection at a Community Hospital Using the Probiotic Combination Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+).
    Maziade PJ; Pereira P; Goldstein EJ
    Clin Infect Dis; 2015 May; 60 Suppl 2():S144-7. PubMed ID: 25922400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.